SCHEMBL14063624

SCHEMBL14063624

COc1ccnc2ccc(-c3ccnc(C(C)(C)C)c3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR2 P21802 3/20 0.45
▸ GAK O14976 1/20 0.41
▸ RIPK2 O43353 1/20 0.41
▸ COQ8A Q8NI60 1/20 0.41
▸ NLK Q9UBE8 1/20 0.41
▸ DOT1L Q8TEK3 1/20 0.41
▸ RAF1 P04049 3/20 0.40
▸ BRAF P15056 3/20 0.40
▸ PDGFRB P09619 2/20 0.40
▸ PDGFRA P16234 2/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26317752 0.78 FGFR2 (0.56) FGFR2DOT1LRAF1BRAFPDGFRB
SCHEMBL14072850 0.77 WNT3A (0.41) DOT1LRAF1BRAFPDGFRBPDGFRA
SCHEMBL14063596 0.74 ACVR2A (0.43) —
SCHEMBL19723173 0.74 HTR1A (0.53) DOT1LPDGFRBPDGFRA
SCHEMBL14063581 0.73 PARP1 (0.56) —
SCHEMBL10220722 0.73 CYP2A6 (0.50) PDGFRBPDGFRAPIK3CA
SCHEMBL28581110 0.71 LMNA (0.61) FGFR2GAKRIPK2COQ8ANLK
SCHEMBL14063615 0.70 KIF11 (0.53) MAPTLMNAPIK3CA
SCHEMBL24010756 0.69 DOT1L (0.48) FGFR2DOT1LPDGFRBPDGFRAKDM4E
SCHEMBL14063628 0.69 DYRK1A (0.42) CYP3A4HPGDKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429604-B2 Six-membered heterocycles useful as serine protease inhibitors BRISTOL MYERS SQUIBB COMPANY (US) 2008-09-30 — — US disclosed
Send feedback